CCNB1 and cholangiocarcinoma: It should be noted that infinite proliferation potential is a common feature for most types of cancer, so CDK1, CCNB1, and KIAA0101 were broadly expressed and upregulated in a variety of cancers, making them unsuitable for use as CCA biomarkers but suitable for therapeutical targets.